Tim Cernak, a former precision medicine researcher at Merck & Co. now serving as an associate professor at the University of Michigan, is pioneering a new interdisciplinary field he calls conservation chemistry. Transitioning from human oncology and virology to wildlife medicine, Cernak applies advanced drug-design methodologies to treat and prevent diseases in endangered species and protect vulnerable ecosystems. His work directly addresses the limitations of current veterinary and ecological treatments, which often rely on human pharmaceuticals repurposed for animals. These traditional approaches, such as the antifungal itraconazole used against chytridiomycosis, a pathogen responsible for the decline of over 500 amphibian species, frequently lack species-specific targeting and carry high toxicity risks. To overcome these challenges, Cernak leverages artificial intelligence and automated laboratory systems to accelerate therapeutic discovery. Utilizing computational models like AlphaFold, his team visualizes complex protein structures without relying on slow, resource-intensive crystallization methods. This capability is critical for studying rare wildlife, where obtaining biological samples is difficult. Coupled with high-throughput screening robotics that process up to 1,500 experiments daily, the workflow dramatically reduces the time and cost required to develop targeted interventions. Cernak research portfolio spans diverse taxa and habitats. He is developing treatments for amphibians afflicted by skin-decaying fungi, bald eagles suffering from avian influenza, red-eared sliders battling infectious tumors, and North American hemlock forests threatened by invasive pests. His approach deliberately centers each conservation intervention on the specific physiological needs of the organism, moving away from blunt chemical applications that have historically caused ecological collateral damage, such as DDT-induced raptor declines or diclofenac-triggered vulture extinctions. By integrating computational biology, synthetic chemistry, and ecological science, conservation chemistry represents a paradigm shift in environmental stewardship. It transforms chemical intervention from a historically problematic tool into a precision technology capable of mitigating anthropogenic biodiversity loss. As the framework matures, it signals a broader convergence of pharmaceutical innovation and ecological conservation, offering scalable solutions to combat emerging wildlife diseases while minimizing unintended environmental harm. This emerging discipline underscores how advanced drug-development infrastructure can be repurposed to safeguard global ecosystems during an ongoing biodiversity crisis.